News about "ViiV Healthcare "

MPP-ViiV Agreement Expanded: Aurobindo, Cipla and Viatris to Make Generic HIV Drug Cabotegravir

MPP-ViiV Agreement Expanded: Aurobindo, Cipla and Viatris to Make Generic HIV Drug Cabotegravir

ViiV Healthcare and the Medicines Patent Pool (MPP) have expanded their voluntary licensing agreement for cabotegravir, enabling manufacturers such as Aurobindo, Cipla, and Viatris to develop, manufacture, and supply generic versions for the HIV treatment in 133 countries.

ViiV Healthcare | 15/07/2025 | By Dineshwori 141

Aurobindo to launch HIV triple combination product for children living with HIV in low and middle-income countries

Aurobindo to launch HIV triple combination product for children living with HIV in low and middle-income countries

Aurobindo to launch HIV triple combination product for children living with HIV in low and middle-income countries under voluntary licence from ViiV Healthcare

ViiV Healthcare | 17/08/2023 | By Sudeep Soparkar 485


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members